PharmaCielo Ltd.
PCLO.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | 44.53% | -8.51% |
| Total Depreciation and Amortization | -- | -- | -- | -32.26% | 204.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -26.36% | 19.78% |
| Change in Net Operating Assets | -- | -- | -- | -63.91% | 1,150.24% |
| Cash from Operations | -- | -- | -- | 66.02% | 43.94% |
| Capital Expenditure | -- | -- | -- | -- | 92.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -89.87% | -83.52% |
| Cash from Investing | -- | -- | -- | -89.48% | -82.30% |
| Total Debt Issued | -- | -- | -- | -57.80% | -42.59% |
| Total Debt Repaid | -- | -- | -- | 12.46% | -19.44% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 492.50% |
| Cash from Financing | -- | -- | -- | -61.13% | -34.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -127.86% | 149.02% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 173.34% | 100.74% |